LCC Consulting, LLC - Moving your science forward
About Us
 
Dr. Lauren C. Costantini is a dynamic leader with over 20 years of experience driving products from research through commercialization. Her insights into “the art and science of building a life science company” allow her to lead emerging companies at various stages of development, fine-tuning their business plans and company strategies. Dr. Costantini has led preclinical development, early and pivotal clinical trials, manufacturing, and regulatory affairs for drugs, devices, medical foods, and supplements, and plays a key role in obtaining investor funding and corporate partnerships, licensing, patent activities, and due diligence. She has an extensive network of national and international key opinion leader and business development partners.  A recognized leader in the area of central nervous system therapeutics, she presents at numerous scientific, investor and partnering conferences.   

Prior to founding her own firm, Dr. Costantini was Vice President at Sierra Neuropharmaceuticals focusing on new treatments for epilepsy, and Vice President of Clinical Development at Accera where she was instrumental in the successful commercialization of an Alzheimer’s product. Dr. Costantini directed Product Development at Titan Pharmaceuticals, developing novel treatments for several indications across drug delivery, gene therapy and cell therapy platforms.    

Prior to industry, she investigated mechanisms and treatments for neurodegenerative diseases while on faculty at Harvard Medical School. Her PhD is in Biomedical Neuroscience.   

Dr. Costantini serves on several boards for companies, journals and grant foundations including the Michael J. Fox Foundation for Parkinson’s Research, and Cool Girls Science and Art Club which helps elementary school girls develop their passion for science and engineering. She is an active advisor in several business and technology advisory groups, and enjoys teaching courses on product translation to investigators interested in commercializing their bioscience discoveries. Dr. Costantini was named ‘Business Advisor of the Year’ in 2011 by University of Colorado Technology Transfer, and has served ‘on the Hill’ to connect neurotechnology to policymakers. 
Website Builder provided by  Vistaprint